Sibelius™: Sage improved secondary memory - immediate word recall, delayed word recognition and recall - with a single dose compared with placebo in both younger and older demographics.
Sibelius™: Sage improved accuracy of attention (choice reaction time, digit vigilance) with a single dose after 60 minutes compared with placebo. In-vitro analysis on Sibelius™: Sage showed considerable anti-cholinesterase inhibition, approximately halving the breakdown of substrate by human cholinesterase.
Sibelius™: Sage showed considerable anti-cholinesterase inhibition (53%), approximately halving the breakdown of the substrate by human cholinesterase. Sibelius™: Sage decreased the pro-inflammatory markers in human adipocytes.
Dr. Kieron Edwards (Chief Science Officer at Sibelius), David Foreman (aka the Herbal Pharmacist®) and Abigail Heaton (Global Marketing Manager at Sibelius) discuss the fast-growing market that is brain health and our clinically proven solution to support consumers’ health.